Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. - Wikidata - awgldk - TriplyDB

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.

http://www.wikidata.org/entity/Q30449273

about

Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching.Multiple cytokines sharing the common receptor gamma chain can induce CD154/CD40 ligand expression by human CD4+ T lymphocytes via a cyclosporin A-resistant pathway Calcineurin-dependent nuclear translocation of a murine transcription factor NFATx: molecular cloning and functional characterization NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice Cyclosporine-resistant, Rab27a-independent mobilization of intracellular preformed CD40 ligand mediates antigen-specific T cell help in vitro.Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.Targeting CD40L: a promising therapeutic approach.Human CD14hi monocytes and myeloid dendritic cells provide a cell contact-dependent costimulatory signal for early CD40 ligand expression Deregulated expression of CD40 ligand in HTLV-I infection: distinct mechanisms of downregulation in HTLV-I-transformed cell lines and ATL patients.Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease.CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study.The hyper IgM syndromes.Utilization of an NF-ATp binding promoter element for EGR3 expression in T cells but not fibroblasts provides a molecular model for the lymphoid cell-specific effect of cyclosporin A.The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription.Effects of Epstein-Barr virus infection on the development of multiple myeloma after liver transplantation.Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells.Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression Evidence that calcineurin is rate-limiting for primary human lymphocyte activation.Functional analysis of a tripartite stability element within the CD40 ligand 3' untranslated region.Paediatric kidney transplantation.Transfer of activation-dependent gene expression into T cell lines by recombinant adeno-associated virus.gamma/delta T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes.Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.Development and validation of a canine T-cell-dependent antibody response model for immunotoxicity evaluation.CD154 expression and mRNA stability of activated CD4-positive T cells in patients with systemic lupus erythematosus.Interleukin-15 up-regulates the expression of CD154 on synovial fluid T cells.CD40LG duplication-associated autoimmune disease is silenced by nonrandom X-chromosome inactivation.Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers.

P2860

Q27480732-06DCA168-17C3-451F-A175-4D25933F9AFA Q28346560-16E5E7DD-0099-47F4-AA16-4A1EC36DF2CB Q28365233-116924B3-CFA8-4141-9BF8-1C8160B7F6DE Q28510716-B6B984F8-AA9D-4592-829A-84225316B266 Q28591436-9BA1F5FB-7E61-4653-8C88-E543C7922172 Q34006170-7CF43CEC-DA2C-4A41-8FF4-C5936ADF5439 Q35091423-6EE331C8-4ABF-4CEA-807F-61B306520F8D Q35794358-7068D950-855D-412E-9155-1ECE4F0F14F5 Q35830859-9810BB18-CAB8-46F7-BC11-71492BE97094 Q35868342-B047E29D-5B9B-4D7D-918A-B5B7B6968685 Q35941655-3588FE4C-7B94-452D-A916-5914214BE160 Q35994774-725FFF20-3C26-4085-A641-9F2B44ABC621 Q36375941-E6715E37-604B-4BE1-A70E-D12A8243B9AD Q36854921-F9694419-C562-43EB-A68F-20E901CC05E9 Q37358432-1E769BB2-67BA-4C68-86EC-AF5B2447C80F Q37715369-C00CADDF-EDE6-4CC2-A989-5BCB56B419E9 Q38116775-9E5B0CC0-132E-4C3D-A221-BD009074C0DC Q38331306-0E746EB6-DC1D-43EA-95D4-280C63F65AC7 Q38361498-2CFCCAD9-FE3E-4540-8C0C-6E4CAEE5333C Q39288709-6678AF01-8D09-4845-9291-FC1029671B89 Q39550464-D75F43B8-BC91-4D4A-9482-75CC4EEA14FC Q39739685-CA46DADF-D137-48F9-B258-315A6C28DA9D Q39792111-57AB689D-2381-4317-BA45-9939881A73AA Q40025338-D94076DE-F5A1-42DA-8D7E-61F9CB907833 Q40862165-7001F52A-C9D1-4E88-82FA-EA6F70FB41B4 Q40937509-8FCC0443-3B5F-46BD-932A-13DF039966DE Q42942856-93FB3DC0-A5C2-400D-9CAE-33A16B653C37 Q43988928-E7AECA20-C61E-4D19-8AC9-BA80D7F84437 Q46287449-A06BC9CB-6600-4F71-BBBA-6DEDEE9E872D Q47702525-36DCDB60-02AF-4B3D-9ADF-C603CF8011BF Q52025999-3D2CB0CA-10DF-4484-8965-0B225AF36F2F Q52676983-7E5BB164-7FA1-48AE-B990-EE4ED6C3F922 Q54059237-8BBA1CE4-55FF-4689-96BC-F3476FB0101D

P2860

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.

http://www.wikidata.org/entity/Q30449273

description

1994 nî lūn-bûn

@nan

1994 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի մարտին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.

@ast

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.

@en

type

label

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.

@ast

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.

@en

prefLabel

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.

@ast

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.

@en

P1433

Q30449273-E20CBAA9-3DD6-4394-99A1-446DD3F1EB33

P1476

Q30449273-CD715CA8-7D55-40B0-82BB-AF35D4595B0E

P2093

Q30449273-06F5CBE1-9A51-4332-91F3-9733B51B0802

Q30449273-06FD0101-AA49-4A78-84E1-1FA8E6BE2FA2

Q30449273-1668742F-8F57-42A1-9917-66B535D7AE63

Q30449273-19389304-D5B6-4F23-B368-83D1095FBF52

Q30449273-319F795D-BCED-41F0-90BC-20A0567B6501

Q30449273-5746E171-CBB8-45A0-84D4-BC77E0CFF32D

Q30449273-618727F6-AEAD-4136-A88B-3929B95EE8EE

Q30449273-8E991B7E-196D-4DE8-97A1-B9BEA3D11B13

Q30449273-F1580CB4-6CBE-41A3-B1CA-9406FFA80758

P2860

Q30449273-02BA7D3C-13E1-483F-8ED0-1E4B682A0006

Q30449273-08C99D1E-0A4C-49DF-A6A6-0135AB78036C

Q30449273-090C51CD-93D3-4115-B9BA-7C9F3693BA8D

Q30449273-281BC079-DEEE-4999-8594-E3E54C5F2AEB

Q30449273-281EB4D0-4BFE-49C4-908C-4582B0F05DD2

Q30449273-2F186269-8CED-4E13-9A54-C7CF049F3236

Q30449273-3865D06F-83DC-4D26-BC7A-DBA806141801

Q30449273-48CCE208-3AC6-4C21-87CA-88E2BF0DD920

Q30449273-4D16BFE5-48E2-40E7-9D0D-3B30D66BCC06

Q30449273-50731A7A-4195-4ABC-AD5B-472C58D7E786

P304

Q30449273-92BE3248-B6AE-4EF6-8A86-208DB022D645

P31

Q30449273-021975A6-3407-4EE3-8575-810408CE7608

P356

Q30449273-063A9D02-DDE7-4BB9-8306-DA4E5894C8BB

P407

Q30449273-E00B0E68-EC83-4B77-A481-29DB7B231082

P433

Q30449273-A982A6A4-EDA0-49B3-AA41-CE530A1A58F2

P478

Q30449273-FABE777C-0875-4B8A-BF20-840D16B82327

P577

Q30449273-E31E6A4A-9803-482A-8E06-989B861DC8BE

P5875

Q30449273-234D9756-0DB2-4C83-9C2F-126E57580E46

P698

Q30449273-752B1543-4BCD-40A1-BC56-A5D885274525

P932

Q30449273-4CC0D480-8727-4848-A129-E10D98CC7EAB

P356

P1433

Journal of Clinical Investigation

P1476

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.

@en

P2093

A Horner

http://www.w3.org/2001/XMLSchema#string

D Ahern

http://www.w3.org/2001/XMLSchema#string

D G Alberg

http://www.w3.org/2001/XMLSchema#string

I Stamenkovic

http://www.w3.org/2001/XMLSchema#string

N Ramesh

http://www.w3.org/2001/XMLSchema#string

P J Belshaw

http://www.w3.org/2001/XMLSchema#string

R Fuleihan

http://www.w3.org/2001/XMLSchema#string

R S Geha

http://www.w3.org/2001/XMLSchema#string

W Harmon

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help)

A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas

Molecular and biological characterization of a murine ligand for CD40

A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells

CD44 is the principal cell surface receptor for hyaluronate

The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A

Inositol trisphosphate, a novel second messenger in cellular signal transduction

The role of protein kinase C in cell surface signal transduction and tumour promotion

P304

1315-1320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI117089

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

1994-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15290837

http://www.w3.org/2001/XMLSchema#string

P698

7907604

http://www.w3.org/2001/XMLSchema#string

P932

294093

http://www.w3.org/2001/XMLSchema#string